Clinical Trials Logo

Clinical Trial Summary

The START-POAF pilot study is a prospective, open-label two-arm, randomized controlled trial with blinded assessment of outcomes (PROBE). This pilot study will assess Atrial Fibrillation (AF) recurrence and burden in patients with new-onset AF following cardiac surgery.


Clinical Trial Description

Atrial fibrillation (AF) is the most common abnormal heart rhythm in the world. In patients who have cardiac surgery, new AF is found as an early complication in more than one out of every four surgeries. In the weeks and months after heart surgery, patients who have new AF take a medication called amiodarone to keep their heart in rhythm as it heals. If the heart goes back into AF, patients can have symptoms of heart racing, heart failure (fluid on the lungs) or stroke. Although amiodarone is effective, it can have side effects like dizziness, nausea and slow heart rate. It may also damage the lungs, liver and thyroid gland. Many patients are not able to complete their full prescribed course after surgery. Therefore, it is crucial that the investigators find the shortest possible length of treatment with amiodarone that will keep the heart in rhythm while minimizing the chance of side effects or organ damage. The START-POAF Pilot Randomized Trial will compare two different durations of amiodarone treatment: 1) in-hospital load only and 2) in-hospital load plus 4 weeks after loading dose. All participants will wear an electrocardiogram (ECG) monitor for 4 weeks the day after they complete their loading dose. The investigators will compare the amount of AF seen on the ECG between the two groups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05841056
Study type Interventional
Source Population Health Research Institute
Contact Ingrid Copland
Phone 905-512-4940
Email start-poaf@phri.ca
Status Not yet recruiting
Phase Phase 3
Start date May 31, 2024
Completion date January 30, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06055751 - Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
Recruiting NCT04870424 - Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Phase 3
Completed NCT05818592 - Screening for Atrial Fibrillation With Self Pulse Monitoring N/A
Active, not recruiting NCT05780320 - A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
Active, not recruiting NCT03866148 - Obstructive Sleep Apnoea and Cardiac Arrhythmias N/A
Withdrawn NCT05656170 - Stellate Ganglion to Prevent Atrial Fibrillation N/A
Active, not recruiting NCT05255224 - PARADISE: Predicting AF After Cardiac Surgery
Recruiting NCT04528511 - BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
Recruiting NCT04857268 - Diagnostic Validation of Wearable ECG Monitoring Patch, ATP-C120 N/A
Completed NCT04118270 - Shared Decision-Making: AFib 2gether Mobile App N/A
Active, not recruiting NCT03345615 - Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation N/A
Recruiting NCT06275503 - STROKESTOP III - Optimized Method for Atrial Fibrillation Screening N/A
Recruiting NCT05149820 - Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments Phase 4
Completed NCT03221777 - Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
Not yet recruiting NCT03991754 - Prevention of New Onset AF After TAVI (PAF-TAVI Trial) Phase 3
Completed NCT03118518 - STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation N/A
Completed NCT03552588 - High Sensitivity Estimate of the Incidence of Atrial Fibrillation Occurring Transiently With Stress (AFOTS Incidence Study)
Recruiting NCT05444335 - Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years N/A
Not yet recruiting NCT06458829 - Promoting Atrial Fibrillation Screening in Primary Care N/A
Terminated NCT05950971 - Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation N/A